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Abstract: Ruminal microbiota of cattle are not able to detoxify all mycotoxins. In addition, detoxification
can be hampered by adverse ruminal conditions (e.g., low ruminal pH). Hence, in the cattle husbandry,
mycotoxin binders and modifiers could be used to prevent animal exposure to mycotoxins. In this
study, an in vitro rumen model, including feed matrix, was established as first screening tool to test the
efficacy of five products claiming to detoxify mycotoxins. The detoxifiers had different modes of action:
(a) binding (three products); (b) enzymatic detoxification of zearalenone (ZEN; one product, ZenA);
and (c) bacterial transformation of trichothecenes (one product, BBSH 797). For the mycotoxin binders,
the binding to the mycotoxins enniatin B (ENN B), roquefortine C (ROQ-C), mycophenolic acid (MPA),
deoxynivalenol (DON), nivalenol (NIV), and zearalenone (ZEN) were tested at a dose recommended
by the manufacturers. The in vitro model demonstrated that all binders adsorbed ENN B to a certain
extent, while only one of the binders also partially adsorbed ROQ-C. The binders did not change the
concentrations of the other mycotoxins in the ruminal fluid. The enzyme ZenA detoxified ZEN very
quickly and prevented the formation of the more toxic metabolite α-zearalenol (α-ZEL), both at normal
(6.8) and low ruminal pH (5.8). The addition of BBSH 797 enhanced detoxification of DON and NIV,
both at normal and low ruminal pH. The in vitro rumen model demonstrated that the addition of
ZenA seems to be a very promising strategy to prevent estrogenic effects of ZEN contaminated feed,
and BBSH 797 is efficient in the detoxification of trichothecenes.
Keywords: mycotoxins; maize silage; mycotoxin binders; mycotoxin modifiers; efficacy testing
Key Contribution: The efficacy of several mycotoxin detoxifying agents was tested in a newly developed
in vitro rumen model. In this study, different products claiming to detoxify mycotoxins were investigated:
three mycotoxin binders, one enzyme claiming to detoxify zearalenone (ZenA), and one bacterial strain
claiming to detoxify trichothecenes (BBSH 797). The results show that ZenA and BBSH 797 are promising
mycotoxin modifiers to detoxify ZEN or deoxynivalenol and nivalenol in contaminated feeds, respectively.
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1. Introduction
Dairy cattle are often exposed to mycotoxins as high yielders are given a large proportion of
maize silage in their ration [1]. Indeed, maize silage is more prone to contamination with multiple
mycotoxins compared to grassland products [2–4]. In countries with a temperate climate, enniatin B
(ENN B), roquefortine C (ROQ-C), mycophenolic acid (MPA), deoxynivalenol (DON), nivalenol (NIV),
and zearalenone (ZEN) are often found in maize silage [2,5–7]. Previous research has demonstrated
that some mycotoxins remain intact in the rumen (e.g., MPA) and that the degradation of mycotoxins
is strongly dependent on the rumen conditions [8–10]. Hence, for ruminants, detrimental health effects
and economic losses in animal production occur, which emphasizes the importance of minimizing
mycotoxin exposure.
Numerous strategies have been developed to prevent animal exposure to mycotoxins.
As mycotoxins are produced in the field, during post-harvest handling and/or during storage, prevention
of mycotoxin production by applying good agricultural practices (GAP) is one of the most important
actions to take. Examples of pre-harvest GAP include crop rotation, tillage, use of less susceptible
cultivars, application of fungicides, and stem borer control with insecticides [11–13]. Examples of
harvest and post-harvest GAP are reducing contamination with soil during harvest, reducing humidity
level before and during storage, and packing silages tightly to preserve anaerobic conditions [11–13].
However, a complete avoidance of mycotoxin contamination of food and feedstuffs is impossible as
certain factors that promote mycotoxin production are out of human control, e.g., weather conditions
and soil type. Therefore, physical treatments of contaminated grains including density segregation
to remove damaged grains, washing and dehulling or reduction of fungal spore contamination by
irradiation, or chemical treatments can be applied [11–13]. Another commonly used approach to reduce
the exposure to mycotoxins in animal feed, is the addition of mycotoxin detoxifying agents (mycotoxin
detoxifiers) [11–14]. Mycotoxin detoxifiers can be divided into two subcategories: adsorbing agents
(mycotoxin binders) and biotransforming agents (mycotoxin modifiers). Each subcategory has its own
mode of action; binders adsorb mycotoxins in the gastrointestinal tract to enhance the fecal excretion
of mycotoxin-binder complexes and prevent mycotoxin absorption, whereas mycotoxin modifiers
transform mycotoxins by microorganisms/enzymes into non- or less-toxic metabolites [15].
In contrast to monogastric animals, mycotoxin detoxifiers have not been well investigated in
ruminants, except with regards to aflatoxins, given the transfer of their carcinogenic metabolite
aflatoxin M1 to the milk. Nonetheless, mycotoxin detoxifiers could also protect ruminants against
other mycotoxins since it has been demonstrated that some mycotoxins remain intact in the rumen
and ruminal detoxification can be hampered by various factors such as rumen acidosis and microbial
activity [8–10]. Thus, it is also worth testing the efficacy and safety of mycotoxin detoxifiers in ruminants.
In 2009, the European Food Safety Authority (EFSA) established a functional group of technological
feed additives called ‘substances for reduction of the contamination of feed by mycotoxins’ and
published guidelines for applicants in 2010 on how to conduct the safety and efficacy assessment of
mycotoxin detoxifiers [16]. As a first screening tool, in vitro studies are preferred to reduce the use of
laboratory animals [15,17].
In vitro models to study the efficacy of mycotoxin detoxifying agents include static and dynamic
models. Static models are suited as a first screening tool as they are cheap and labor efficient. However,
they are less representative for the whole gastrointestinal tract and results should be interpreted
carefully. Static models are usually based on a buffer system and do not include feed, although feed is
always present in the in vivo situation. Dynamic models on the other hand are usually composed of
different compartments mimicking the different segments of the gastrointestinal tract [15]. As these
models are rather time consuming, require many resources and only allow a limited number of
replicates, they are not suitable for first screening experiments. To the authors’ knowledge, no static
in vitro model mimicking the rumen metabolism, including both rumen inoculum as well as feed has
been reported yet.
Toxins 2020, 12, 405 3 of 18
In this study, a static in vitro rumen model with the presence of feed was established as first
screening tool to test the efficacy of five products claiming to detoxify mycotoxins. The detoxifiers had
differently claimed modes of action: (a) binding (three products); (b) enzymatic detoxification of ZEN
(one product, ZenA); and (c) bacterial transformation of trichothecenes, such as DON and NIV (one
product, BBSH 797). For the mycotoxin binders, the binding to the mycotoxins DON, NIV, ENN B,
MPA, ROQ-C, and ZEN were tested.
2. Results and Discussion
Four consecutive in vitro experiments were performed:
1. Each mycotoxin binder was mixed into feed. The efficacy of the binders was tested at normal
rumen pH (6.8) [18].
2. The enzyme ZenA was added to feed. The efficacy of this mycotoxin biotransforming agent was
initially tested at normal rumen pH (6.8).
3. An additional experiment with ZenA was performed to test the activity of the enzyme at different
pH levels. Hence, the enzyme was added to the rumen fluid–buffer mixture at two different pH
levels just before incubation: low pH (5.8 [18]) and normal pH (6.8).
4. The anaerobic bacterial strain BBSH 797 was added to the rumen fluid–buffer just before incubation
as to avoid contact with oxygen. The efficacy of this mycotoxin biotransforming agent was tested
at two different pH levels (5.8 and 6.8).
For each experiment, mycotoxin concentrations are expressed relative to the maximal (free)
mycotoxin concentration detected during the in vitro rumen simulation study without the addition of
the detoxifiers. Hence, the presentation and interpretation of the results is facilitated as mycotoxins
might adsorb to feed or other particles in rumen fluid. Indeed, bacteria and yeast cell walls could
be involved in adsorbing aflatoxins, DON, ZEN, and fumonisins [19–27]. Moreover, we previously
demonstrated that ENN B, ROQ-C, and ZEN might be adsorbed to maize silage while MPA was shown
to adsorb to rumen fluid particles [28]. During the in vitro incubation, these adsorbed mycotoxins are
possibly released, as could be the case when feed particles are degraded. Consequently, mycotoxin
concentrations could increase with progressing incubation time as only the free mycotoxin fraction
is determined.
2.1. Binders in Feed, Normal Rumen pH (6.8)
Just like in our previous study [8], the change in relative mycotoxin concentration compared to
the maximal (parent) mycotoxin concentration in rumen fluid is described by means of models which
include time, rumen pH, treatment, and interactions between treatment if significant. The final models
are given in Supplementary Figures S1–S8 and Tables S1–S6.
On average, over all incubation times, binder 1 reduced ENN B and ROQ-C concentrations by
24% and 11%, respectively, compared to the control treatment, suggesting that the binder adsorbs
those mycotoxins to a certain extent. However, addition of binder 1 increased DON concentrations
compared to the control treatment, although the small statistical difference of 4.9% (p = 0.0124)
is irrelevant as this difference falls within the range of analytical precision of the UPLC-MS/MS
method (relative standard deviation (RSD) for DON: ±5.2%) [29]. No effect of binder 1 on the MPA,
deepoxy-deoxynivalenol (DOM-1), NIV, ZEN, and α-zearalenol (α-ZEL) concentration was observed
compared to the control treatment.
According to the provider, binder 1 includes clay minerals and yeast derivatives. The types of
clay minerals were not specified by the manufacturer. Clay minerals are mainly effective in binding
aflatoxins [15]. Hence, this product could be a good candidate to test binding of aflatoxins in the
rumen model. Yeast derivatives are reported to adsorb ZEN by complexation with β-D-glucans in
water or buffer solutions [30,31]. The more complex the matrix is (e.g., addition of feed matrix), the
higher the chance that the matrix reduces the apparent affinity and capacity of the adsorbents for
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mycotoxins [15]. Hence, it is possible that the feed particles compete with the adsorbent and hence,
the efficacy of the binder decreases [15]. Furthermore, Lauwers et al. demonstrated that the ratio
between the concentration of mycotoxins and binder may also influence the binding efficacy [32].
Hence, a too low dose of the product could also have been the reason no effect was seen on the free
ZEN concentration.
Binder 2 adsorbed ENN B by 28%, although the difference between the ENN B concentration in the
control and binder 2 treatment decreased over time, which could indicate an unstable and reversible
adsorption of ENN B. Nivalenol concentrations were statistically higher with binder 2 compared to
the control treatment, although the biological relevance of the small difference of 6.7% (p = 0.00587) is
considered to be negligible as this difference also falls within the range of precision of the UPLC-MS/MS
method (RSD for NIV: ±7.8%) [29]. No effect of this binder on the ROQ-C, MPA, DON, DOM-1, ZEN,
and α-ZEL concentrations was noted compared to the control treatment.
Binder 2 includes bentonite, leonardite, plant extracts, an epoxidase claimed to be capable to
detoxify DON and NIV, and an esterase claimed to be capable to detoxify ZEN. Ramos et al. tested six
adsorbents in a simulated intestinal fluid and demonstrated that bentonite is able to adsorb ZEN for
only 112.4 µg ZEN/g adsorbent, whereas the best performing binder tested adsorbed 313.7 µg ZEN/g
adsorbent, which indicates that bentonite was not the most effective one [33]. In addition, rumen
fluid is more complex than simulated intestinal fluid as it contains feed and rumen fluid particles,
which could decrease the efficacy of bentonite. Leonardite, an oxidation product of lignite with the
highest humic acid content of any natural source, was shown to effectively bind ZEN and reduce toxic
ZEN effects in gilts [34]. However, for binder 2, no statistical/relevant effect was seen on the ZEN
concentration, despite addition of leonardite and an esterase, or on the NIV and DON concentration,
despite addition of an epoxidase, which could be due to the use of a too low dose and/or less optimal
conditions for the enzymes’ activity. Another explanation is that ZEN could have a higher affinity for
feed particles than for the binder as it has been shown that ZEN could bind to maize silage [28].
ENN B was also adsorbed by binder 3 by 22%. However, as was also observed with binder 2, the
difference between the ENN B concentration in the control and binder 3 treatment reduced over time,
indicating a reversible binding. Binder 3 supplementation was associated with higher MPA (7.7%,
p = 0.00656) and NIV (12.8%, p < 0.001) concentrations compared to the control treatment. As for the
other binders, the small statistical increase seems irrelevant for MPA as this difference falls within
the range of precision of the UPLC-MS/MS method (RSD: ±15.5%). Although the difference for NIV
exceeds the range of analytical precision of the method, this difference becomes negligible over time
due to an interaction between treatment and time [29]. No effect of the binder on the ROQ-C, DON,
DOM-1, ZEN, and α-ZEL concentration was seen compared to the control treatment.
Binder 3 is claimed to contain bentonite and sepiolite as active substances. On the one hand,
these substances are generally used to bind aflatoxins [15,35]. Hence, this product could be a good
candidate to test binding of aflatoxins in the rumen model. On the other hand, Ramos et al. tested
six adsorbents in a simulated intestinal fluid and demonstrated that bentonite and sepiolite are also
able to adsorb ZEN [33]. In this study, bentonite and sepiolite adsorbed only 112.4 and 74.37 µg
ZEN/g adsorbent, whereas the best performing binder tested adsorbed 313.7 µg ZEN/g adsorbent,
which indicates that these adsorbents are not the most effective ones. In addition, rumen fluid is more
complex than simulated intestinal fluid as it contains feed and rumen fluid particles, which could
decrease the efficacy of bentonite and sepiolite. Also, in the case of binder 3, it is possible that a too low
dose was used to see an effect on free ZEN concentrations compared to the control treatment.
An overview of the efficacy of the three binders to adsorb mycotoxins can be seen in Table 1.
In general, the binders adsorbed a maximum of two of the seven tested mycotoxins. The mycotoxins
DON and NIV are hydrophilic, non-ionizable molecules having a rather large epoxide group, which
hampers adsorption to plane surfaces. Hence, only very few adsorbing agents are effective DON and
NIV binders [15]. Activated carbons are, however, reported to be effective binders for the hydrophilic
trichothecenes DON and NIV [15,36]. None of the binders tested contained activated carbons, which
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could explain why the binders did not lower the free concentrations of the hydrophilic compounds
DON, NIV, and DOM-1. However, binder 2 is claimed to contain an epoxidase, which is an enzyme
that could have the potential to detoxify DON and NIV [37]. As only one dose of binder 2 was used
in this study, the concentration of the enzyme could have been too low, which potentially could be a
reason for the lack of effect.
Table 1. Comparison of the effect of three binders on the disappearance of the mycotoxins enniatin
B (ENN B), roquefortine C (ROQ-C), mycophenolic acid (MPA), deoxynivalenol (DON), nivalenol
(NIV), and zearalenone (ZEN) and the metabolite deepoxy-deoxynivalenol (DOM-1) during an in vitro
rumen simulation study of 48 h. Fields marked with a plus-sign (+) mean that the binder adsorbs the
mycotoxin to a certain extent, fields mentioning “No” mean that no statistical/relevant effect was seen
in the presence of the binder.
Mycotoxin Binder 1 Binder 2 Binder 3
ENN B + + +
ROQ-C + No No
MPA No No No
DON No No No
DOM-1 No No No
NIV No No No
ZEN No No No
All binders were able to adsorb ENN B by 24% (binder 1), 28% (binder 2), and 22% (binder 3).
However, as ENN B is an emerging toxin, little is known about mycotoxin binders that could effectively
bind ENN B. Results suggest a stable binding with binder 1, while desorption occurred during
incubation with binders 2 and 3. In case of desorption, the toxic compound is released in the
gastrointestinal tract and can exert its toxic effect again [38].
The action of binder 1 does not seem to be very specific, as the binder can adsorb both ENN B and
ROQ-C, which have different chemical structures. Unspecific adsorption is a major drawback in the
use of mycotoxin binders as these products may also adsorb (micro)nutrients and/or veterinary drugs
and feed additives such as coccidiostats [39]. Hence, nowadays more and more research is done on
targeted modification of the chemical structures of mycotoxins into safe metabolites by using enzymes
or microorganisms.
2.2. ZenA in Feed, Normal Rumen pH (6.8)
Both, ZEN as well as the metabolite α-ZEL exert estrogenic activity by binding to the estrogen
receptor, with α-ZEL being 60 times more potent than its parent toxin ZEN [40]. The detoxifying
enzyme used in this study was the bacterial enzyme zearalenone hydrolase ZenA (ZENzyme®, BIOMIN
Research Center, Tulln, Austria). This enzyme cleaves ZEN to its non-estrogenic hydrolyzed ZEN
(HZEN) metabolite, which spontaneously decarboxylates to DHZEN (Figure 1) [41,42].Toxins 2020, 12, x FOR PEER REVIEW 6 of 18 
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Figure 1. Enzymatical transformation of the estrogenic mycotoxin zearalenone (ZEN) to its hydrolyzed
ZEN (HZEN) and decarboxylated HZEN (DHZEN) metabolites by the bacterial enzyme zearalenone
hydrolase ZenA. Reprint from Fruhauf et al. [43].
When the enzyme was not added, almost 50% of ZEN remained intact at the end of the incubation
of 48 h and the other 50% of ZEN were entirely transformed to the more toxic α-ZEL. Irrespective of
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the dose, enzyme supplementation to ZEN contaminated feed resulted in an immediate and complete
detoxification of ZEN and prevented the formation of the more toxic metabolite α-ZEL (Figures 2 and 3
and Supplementary Table S7). Hence, adding this enzyme to the feed could prevent reproduction
problems caused by ZEN in cattle.
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Figure 2. The effect of the zearalenone hydrolase en enzy e, added to the feed, on the zearalenone
(ZE ) concentration in the in vitro rumen model. The enzyme was tested at two different concentrations
(125 µg/mg feed and 62.5 µg/mg feed) during an incubation period of 48 h. The ZEN concentration is
expressed relative to the maximum ZEN concentration detected. As the enzyme degraded ZEN very
effectively, its concentration was below the detection limit from the first incubation timepoint and for
both enzyme concentrations, resulting in overlapping results of the treatments 62.5 and 125 µg/mg.
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The enzyme was tested at two different concentrations (125 µg/mg feed and 62.5 µg/mg feed) during an
incubation period of 48 h. The molar α-ZEL concentration is expressed relative to the maximum molar
ZEN concentration detected. As the enzyme prevented the accumulation of α-ZEL very effectively, its
concentration was below the detection limit at all incubation times and for both enzyme concentrations,
resulting in overlapping results of the treatments 62.5 and 125 µg/mg.
The markedly reduced estrogenic activity of the metabolites HZEN and DHZEN has already been
confirmed by Fruhauf et al. in two in vitro models and in an in vivo study with piglets [43]. The MCF-7
cell proliferation assay (0.01–500 nM) and an estrogen-sensitive yeast bioassay (1–10,000 nM) were
used as in vitro models. Dependent on the performed test, it was reported that the metabolites HZEN
and DHZEN are at least 50–1000 times less estrogenic than ZEN. In the in vivo study, ZEN markedly
increased the reproductive tract weight, whereas the ZEN metabolites did not. In addition, uterine
mRNA and microRNA expression in female piglets were altered by ZEN but were unaffected by HZEN
and DHZEN. These findings support that the enzyme ZenA might be a promising additive to reduce
the negative effects of ZEN in dairy cattle as well.
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2.3. ZenA in Rumen Fluid, Normal (6.8) and Low (5.8) Rumen pH
As the action of ZenA on ZEN should take place in the rumen, it is important to test if ZenA not
only detoxifies at normal rumen pH (6.8), but also at low rumen pH (5.8), which can occur during rumen
acidosis. Both, at low (62.5 µg/mg feed) and high (125 µg/mg feed) enzyme concentrations, a very fast
detoxification of ZEN occurred (Figure 4 and Supplementary Table S8). At the first sampling point
(0 h), less than 25% of ZEN was recovered and after 1.5 h of incubation, ZEN was no longer detected.
The pH level did not show an effect on the enzyme activity. When no enzyme was added, formation of
the more toxic metabolite α-ZEL, and to a lesser extent β-ZEL, occurred at pH 6.8 (Figures 5 and 6
and Supplementary Table S9), which was prevented completely at both enzyme concentrations. This
suggests that ZenA is an effective feed additive to degrade ZEN in the rumen of dairy cows and hence
to prevent estrogenic effects of ZEN contaminated feed.
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Figure 4. The effect of the zearalenone hydrolase ZenA enzyme, added to the rumen fluid–buffer (RF-B)
mixture with low (5.8) or normal (6.8) pH, on the zearalenone (ZEN) concentration in the in vitro rumen
model. The enzyme was tested at two different concentrations (125 µg/mg feed and 62.5 µg/mg feed)
during an incubation period of 6 h. The ZEN concentration is expressed relative to the maximum ZEN
concentration detected. Negative values produced by the model are irrelevant and correspond with 0%.
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Figure 5. The effect of the zearalenone hydrolase ZenA enzyme, added to the rumen fluid–buffer (RF-B)
mixture with low (5.8) or normal (6.8) pH, on the molar α-zearalenol (α-ZEL) concentration, formed
out of the par nt toxin ZEN, in the in vitro rumen model. The enzyme was test d at two different
concen rations (125 µg/mg feed and 2.5 µg/mg feed) during n incubation peri d of 6 h. The molar
α-ZEL concentration is expressed relative to the maximum molar ZEN concentration detected. At the
low pH of the RF-B mixture and in all treatments with enzyme addition, α-ZEL accumulation was
below the detection limit, resulting in overlapping results.
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Figure 6. The effect of the zearalenone hydrolase ZenA enzyme, added to the rumen fluid–buffer (RF-B)
mixture with low (5.8) or normal (6.8) pH, on the molar β-zearalenol (β-ZEL) concentration, formed
out of the parent toxin ZEN, in the in vitro rumen model. The enzyme was tested at two different
concentrations (125 µg/mg feed and 62.5 µg/mg feed) during an incubation period of 6 h. The molar
β-ZEL concentration is expressed relative to the maximum molar ZEN concentration detected. At the
low pH of the RF-B mixture and in all treatments with enzyme addition, β-ZEL accumulation was
below the detection l mit, resulting in overlappi g results.
2.4. BBSH 797 in Rumen Fluid, Normal (6.8) and Low (5.8) Rumen pH
Lower DON and NIV concentr tions were seen when BBSH 797 was added, which was particularly
was obvious after 24 h of incubation at normal pH (6.8) and after 24 and 48 h of incubation at lower pH
(5.8; Figures 7–9 and Supplementary Tables S10 and S11). At pH 6.8, complete disappearance of DON
occurred at 48 h of incubation and of NIV at 24 h of incubation when BBSH 797 was added, in contrast
to the control treatment. Also at pH 5.8, DON and NIV had disappeared to a greater extent at the end
of the incubation when BBSH 797 was added. This demonstrates the potential efficacy of BBSH 797 to
induce a quicker detoxification of trich thecenes i the rumen of cows both at ormal and low pH.
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Figure 7. The effect of the mycotoxin detoxifying bacterial strain BBSH 797, added to the rumen
fluid–buffer (RF-B) mixture with low (5.8) or normal (6.8) pH, on the deoxynivalenol (DON)
concentration in the in vitro rumen model during an incubation period of 48 h. The DON concentration
is expressed relative to the maximum DON concentration detected.
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Previous in vitro research has already proven that the bovine rumen microorganism genus novus 
species novus BBSH 797 of the Coriobacteriaceae family can detoxify trichothecenes by cleavage of the 
12,13-epoxide ring (Figure 10) [44]. The safety and efficacy of this ruminal microorganism has been 
assessed by EFSA for the use in piglets as well as fattening pigs and chickens [45], and has been 
approved as feed additive for pigs [46] and all avian species by the European Commission [47]. 
Figure 8. The effect of the mycotoxin detoxifying bacterial strain BBSH 797, added to the rumen
fluid–buffer (RF-B) mixture with low (5.8) or normal (6.8) pH, on the molar deepoxy-deoxynivalenol
(DOM-1) concentration, formed out of the parent toxin DON, in the in vitro rumen model during an
incubation period of 48 h. The molar DOM-1 concentration is expressed relative to the maximum molar
DON concentration detected.
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Figure 9. Effect of the mycotoxin detoxifying bacterial strain BBSH 797, added to the rumen fluid–buffer
(RF-B) mixture with low (5.8) or normal (6.8) pH, on the nivalenol (NIV) concentration in the in vitro
rumen model during an incubation period of 48 h. The NIV concentration is expressed relative to the
maximum NIV concentration detected. Negative values produced by the model are irrelevant and
correspond with 0%.
Previous in vitro research has already proven that the bovine rumen microorganism genus novus
species novus BBSH 797 of the Coriobacteriaceae family can detoxify trichothecenes by cleavage of the
12,13-epoxide ring (Figure 10) [44]. The safety and efficacy of this ruminal microorganism has been
assessed by EFSA for the use in piglets as well as fattening pigs and chickens [45], and has been
approved as feed additive for pigs [46] and all avian species by the European Commission [47].
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Figure 10. Opening of the toxic 12,13-epoxide ring of trichothecenes, such as DON and NIV, leads to a
detoxified form. Reprint from Jenkins [48].
The efficacy of BBSH 797 is not yet reported in a rumen model as ruminants are known to detoxify
trichothecenes by their rumen microbiota. In addition, as BBSH 797 is a strain that naturally occurs in
the rumen microbiota, it is difficult to obtain significant detoxification data. However, as demonstrated
already in a previous in vitro rumen study, the detoxification of trichothecenes can be hampered due to
unfavorable rumen conditions [8]. Low pH (5.8) and inoculum from non-lactating cows, which have a
lower VFA production compared to inoculum from lactating cows, hampered the detoxification of
DON and NIV. In the current study, rumen fluid of dry cows was chosen as the respective microbiota
is less active than that of lactating cows and the detoxification of DON and NIV is more challenged.
The results of our study are promising, as a clear positive effect of the additive on the detoxification was
seen. However, these results should be confirmed with an in vivo trial as in vitro rumen experiments
cannot completely mimic the complex nature of the in vivo rumen situation. Nonetheless, in this case,
the in vitro situation is less favorable for the strict anaerobic bacterial strain as it is partially exposed
to oxygen during the experiment. However, exposure to oxygen was reduced to the minimum as a
reducing agent was added to the buffers and the bacterial strain was only added to the incubation
flasks after 2 h of incubation when the redox potential should have been stabilized [49].
In conclusion, in vitro results demonstrate that adding BBSH 797 as feed additive is a promising
strategy to improve microbial detoxification of trichothecenes in ruminants, especially when
detoxification is hampered as during rumen acidosis.
3. Conclusions
The described in vitro rumen model, which includes ruminal inoculum as well as a feed matrix,
is a suitable first screening tool to investigate the efficacy of mycotoxin detoxifying agents. The model
allows easy customization according to the products tested (e.g., anaerobic addition of bacterial strain).
This study revealed that all binders adsorbed ENN B to a certain extent while only one of the binders
also adsorbed ROQ-C, which has a different chemical structure compared to ENN B. The addition
of ZenA is a very promising strategy to detoxify ZEN in contaminated feed and in rumen fluid with
normal (6.8) or low (5.8) pH. Also, the addition of BBSH 797 as feed additive is a promising strategy to
improve microbial detoxification of DON and NIV in the rumen, both, at normal and low pH.
4. Materials and Methods
4.1. Rumen Fluid, Maize Silage, Mycotoxins, Chemicals, Reagents, and Mycotoxin Detoxifiers
Rumen fluid was collected from three fistulated Holstein-Friesian cows of 2nd, 4th, and 6th
parity, respectively, prior to the morning feeding (EC2015/257; EC of the Institute for Agricultural,
Fisheries and Food Research, approved on 10 August 2015). The collected rumen fluid was immediately
transferred to the lab in thermos flasks before preparing the buffer–rumen fluid mixture (see Section 4.2).
The diet of the cows can be found in Table 2.
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Maize silage, as substrate for the incubation, was obtained from Agrivet (Melle, Belgium) in
May 2012, and was lyophilized and stored at ambient temperature as standard incubation substrate.
A validated multi-mycotoxin LC-MS/MS method was used to determine the mycotoxin concentrations in
the lyophilized maize silage sample. This was performed at the Centre of Excellence in Mycotoxicology
and Public Health, Department of Bioanalysis at Ghent University (Belgium). Only traces of ROQ-C
(12 µg/kg), NIV (201 µg/kg), DON (593 µg/kg), and ZEN (68 µg/kg) were detected. The concentration
of ENN B was below the cut-off value of 80 µg/kg.
Table 2. Ingredients (expressed in kg) of the ration given to rumen fluid donor cows used to test
mycotoxin binders and modifiers in an in vitro rumen model. Study 1: binders added to feed with
normal rumen pH (6.8). Study 2: ZenA added to feed with normal rumen pH (6.8). Study 3: ZenA
added to rumen fluid with normal (6.8) and low (5.8) rumen pH. Study 4: BBSH 797 added to rumen
fluid with normal (6.8) and low (5.8) rumen pH. Indication of “/” means that the component was not
present in the diet.
Diet Components
(kg)
Study 1 (Lactating Cow n◦) Study 2 (Lactating Cow n◦) Study 3 & 4 (Dry Cow n◦)
n◦ 1 n◦ 2 n◦ 3 n◦ 1 n◦ 2 n◦ 3 n◦ 1 n◦ 2
Maize silage 22.62 22.62 21.3 22.62 21.3 21.3 17.3 17.3
Grass silage 18.06 18.06 14.5 18.06 14.5 14.5 20.1 20.1
Maize meal 0.85 0.85 2.0 0.85 2.0 2.0 0.9 0.9
Sugar beet pulp / / 8.7 / 8.7 8.7 7.2 7.2
Straw / / 0.3 / 0.3 0.3 0.2 0.2
Soybean meal / / 1.4 / 1.4 1.4 1.7 1.7
Crushed barley / / 0.2 / 0.2 0.2 0.24 0.24
Sodium
bicarbonate / / 0.2 / 0.2 0.2 0.2 0.2
The analytical standards of ROQ-C, MPA, DON, NIV, and ZEN were purchased from Fermentek
(Jerusalem, Israel). The standards of ENN B, DOM-1, α-ZEL, β-ZEL, α-ZAL, β-ZAL, and ZAN
were purchased from Sigma–Aldrich (Overijse, Belgium). The internal standards (IS) 13C22-ROQ-C,
13C17-MPA, and 13C18-ZEN were purchased from Food Risk Management (Oostvoorne, The
Netherlands). The IS 13C15-DON was purchased from Sigma–Aldrich. The IS 15N3-ENN B was
synthesized as reported earlier [50].
Methanol (MeOH), acetonitrile (ACN), and water (H2O) were purchased from Biosolve
(Valkenswaard, The Netherlands) and were of ULC/MS grade. Hydrochloric acid (HCl) 37%, acetic acid
(AA), ethanol, and ethyl acetate (EtAc) were obtained from Merck Millipore (Overijse, Belgium) and were
of analytical grade. Ammonium hydrogen carbonate (NH4HCO3) and potassium dihydrogenphosphate
(KH2PO4) were purchased from VWR (Leuven, België), while the phosphate-buffered saline (PBS)
powder packs were from Thermo Fisher Scientific (Merelbeke, Belgium). Disodium hydrogen phosphate
dodecahydrate (Na2HPO4·12H2O) and magnesium chloride hexahydrate (MgCl·6H2O) were from Carl
Roth (Vienna, Austria). Sodium hydrogen carbonate (NaHCO3), MES (2-(N-morpholino)ethanesulfonic
acid, 4-morpholineethanesulfonic acid), and L-cysteine hydrochloride monohydrate were purchased
from Sigma–Aldrich (Overijse, Belgium). Carbon dioxide (CO2) was purchased from Air Liquide
(Aalter, Belgium).
Three mycotoxin binders were tested. Binder 1 was a mixture of clay minerals and yeast derivatives.
Binder 2 contained bentonite, leonardite, plant extracts, epoxidase, and esterase. Binder 3 was a
mixture of several clay minerals (bentonite and sepiolite). The ZEN detoxifying enzyme zearalenone
hydrolase ZenA (ZENzyme®) was provided by BIOMIN as well as the BBSH 797 bacterial strain to
detoxify trichothecenes such as DON and NIV.
4.2. Standard Solutions and Rumen Fluid–Buffer Mixtures
Stock solutions of 1 mg/mL in ACN were prepared for ENN B, ROQ-C, MPA, DON, NIV, and ZEN,
and of 100 µg/mL in ACN for α-ZEL, β-ZEL, α-ZAL, β-ZAL, and ZAN. DOM-1 was in solution upon
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purchase (50 µg/mL ACN). An IS-stock solution of 5 µg/mL in ACN was prepared for 15N3-ENN B. All
other IS were in solution upon purchase, i.e., 13C15-DON: 25.3 µg/mL in ACN; 13C17-MPA: 25.4 µg/mL
in ACN; 13C22-ROQ-C: 25 µg/mL in ACN; and 13C18-ZEN: 25.4 µg/mL in ACN. The standard and
IS stock solutions were used to prepare appropriate working solutions for the spiking experiments
(see Section 4.3), and matrix-matched calibrator and quality control (QC) samples (see Section 4.4).
All stock and working solutions were stored at ≤−15 ◦C.
The buffer used for the in vitro rumen simulations performed only with normal rumen pH
(mentioned under Sections 4.3.1 and 4.3.2) and for dissolving the BBSH 797 detoxifier contained the
following salts per liter: 1.55 g KH2PO4, 3.58 g Na2HPO4·12H2O, 0.124 g MgCl2·6H2O, 8.74 g NaHCO3,
and 1.00 g NH4HCO3. The buffer was saturated with CO2 overnight and kept at 39 ◦C.
The buffer used for the in vitro rumen simulations performed at low and normal pH (mentioned
under Sections 4.3.3 and 4.3.4) contained the following compounds per liter: 54.31 g MES, 0.124 g
MgCl2·6H2O, 8.74 g NaHCO3, and 1.00 g NH4HCO3. The buffer was also saturated with CO2 overnight
and kept at 39 ◦C. Before adding to the rumen fluid, 500 mg of reducing agent L-cysteine hydrochloride
monohydrate per liter buffer was added and pH was adjusted with 6 M of HCl to 6.8 or 5.8.
For all rumen fluid–buffer mixtures, fresh rumen fluid from different cows was sieved using a
sieve with mesh width of 1 mm, mixed together, and then added to the buffers. The rumen fluid/buffer
ratio was 263.2 mL/1000 mL.
4.3. In Vitro Rumen Simulation Experiments
4.3.1. Binder in Feed, Normal Rumen pH
Each binder was mixed at a ratio of 3 g per kg maize silage, according to the recommended dose
indicated by the manufacturer, with a Turbula shaker mixer (Eskens, Mechelen, Belgium). A spiking
solution of mycotoxins was prepared and contained 2.5 µg/mL ENN B, 5 µg/mL ROQ-C, 15 µg/mL
MPA, 30 µg/mL DON, 150 µg/mL NIV, and 7.5 µg/mL ZEN, dissolved in ethanol/H2O (50/50, v/v).
Twenty µL of the spiking solution was added to 50 mg of maize silage with mycotoxin binder in an
incubation flask of 25 mL, thus the maize silage contained 1 mg/kg ENN B, 2 mg/kg ROQ-C, 6 mg/kg
MPA, 12 mg/kg DON, 60 mg/kg NIV, and 3 mg/kg ZEN. For DON and ZEN, the concentrations were
based on the maximum guidance levels in maize by-products published by the Commission of the
European Communities [51]. As no maximum guidance levels are available for the other mycotoxins,
the concentrations were based on worst case contamination levels in maize silage found in Belgium
and the Netherlands [2,5–7,52]. After adding 200 µL of distilled water, the incubation flasks were
flushed with CO2 and 4.8 mL of fresh rumen fluid–buffer mixture was added. The samples were
incubated in triplicate at 39 ◦C in a shaking incubator (Edmund Bühler TH30; Edmund Bühler GmbH,
Hechingen, Germany). After 1.5 h, 3 h, 6 h, 24 h, and 48 h, 1 mL of rumen fluid sample was taken to
determine the mycotoxin concentrations.
4.3.2. ZenA in Feed, Normal Rumen pH
A spiking ZEN solution was prepared at 7.5 µg/mL ZEN, dissolved in ethanol/H2O (50/50, v/v).
Twenty µL of the spiking solution was added to 50 mg of maize silage in an incubation flask of 25 mL,
to obtain a concentration of 3 mg/kg ZEN. Just before starting the incubation, the zearalenone hydrolase
ZenA enzyme was dissolved in demineralized water at two different concentrations, i.e., 15.625 mg/mL
(low concentration or 62.5µg/mg feed) and 31.25 mg/mL (high concentration or 125µg/mg feed). To each
incubation flask, 200 µL of demineralized water (control), or enzyme solution at low concentration or
at high concentration was added. The incubation flasks were flushed with CO2 and 4.8 mL of fresh
rumen fluid–buffer mixture was added. The samples were incubated in triplicate at 39 ◦C in a shaking
incubator. After 1.5 h, 3 h, 6 h, 24 h, and 48 h, 250 µL of the rumen fluid sample was taken to determine
the mycotoxin concentrations.
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4.3.3. ZenA in Rumen Fluid, Normal and Low pH
This experiment was performed as described in Section 4.3.2 with some small modifications. After
adding maize silage and the mycotoxin solution to the incubation flasks, the flasks were flushed with
CO2 and 4.8 mL of fresh rumen fluid–buffer mixture at pH 5.8 or pH 6.8 was added. To each incubation
flask, 200 µL of demineralized water (control), or enzyme solution at low or high concentration was
added just before incubation. The incubation lasted only for 6 h with sample collection at 1.5 h, 3 h,
and 6 h.
4.3.4. BBSH 797 in Rumen Fluid, Normal and Low pH
A mycotoxin spiking solution was prepared at 30 µg/mL DON and 150 µg/mL NIV, dissolved in
ethanol/H2O (50/50, v/v). Twenty µL of the spiking solution was added to 50 mg of maize silage in an
incubation flask of 25 mL, to obtain a concentration of 12 mg/kg DON and 60 mg/kg NIV. After adding
200 µL of distilled water, the incubation flasks were CO2 flushed and 4.8 mL of fresh rumen fluid–buffer
mixture was added. The samples were incubated in triplicate at 39 ◦C in a shaking incubator. After 2 h
of incubation, the BBSH 797 detoxifier was dissolved in the CO2 flushed phosphate bicarbonate buffer
(0.1 g per mL buffer) and 200 µL of the detoxifier (treatment) or buffer without detoxifier (control) was
added to the flasks. After another 3 h, 6 h, 24 h, and 48 h of incubation, 250 µL of the rumen fluid
sample was taken to determine the mycotoxin concentrations.
4.4. Calibrator and Quality Control (QC) Samples Used for Mycotoxin Analysis
Matrix-matched calibration curves were prepared for each combination of rumen fluid–buffer
mixture. The appropriate combined working solution was added to 250 µL of rumen fluid–buffer
mixture to obtain a calibration range of 0.05–15 ng/mL of ENN B, 0.10–30 ng/mL of ROQ-C, 0.3–90 ng/mL
of MPA, 0.6–180 ng/mL of DON and DOM-1, 30–900 ng/mL of NIV, and 0.15–45 ng/mL of ZEN, α-ZEL,
β-ZEL, α-ZAL, β-ZAL, and ZAN. Quality control samples were prepared at low (10% of the initial
concentration in spiked samples) and high (initial concentration in spiked samples) concentration levels.
4.5. Rumen Fluid Sample Extraction and LC-MS/MS Mycotoxin Analysis
Samples from the in vitro experiment with the binders were first centrifuged (3724× g, 5 min,
4 ◦C) to precipitate the binder and mycotoxin-binder complexes. A subsample of 250 µL was taken to
extract the mycotoxins. The procedure as described in Debevere et al. [29] was applied to extract ENN
B, ROQ-C, MPA, DON, DOM-1, NIV, ZEN, and possible metabolites, with some small modifications.
In brief, 25 µL of the IS-mix working solution (10 ng/mL for 15N3-ENN B and 13C22-ROQ-C, 100 ng/mL
for 13C15-DON, 13C17-MPA, and 13C18-ZEN), 250 µL of PBS, and 1.5 mL of EtAc were added to the
250 µL rumen fluid sample. The samples were vortexed mixed and extracted on an overhead shaker
(Trayster digital, IKA, Staufen, Germany) for 15 min. After centrifugation (3724× g, 5 min, 4 ◦C), the
upper organic phase was collected and evaporated to dryness under a gentle stream of nitrogen at
~50 ◦C. The dry residue was redissolved in 200µL of H2O/ACN (85/15, v/v), vortex mixed, filtrated using
a 0.20 µm Millex®-LG PTFE filter (Merck, Overijse, Belgium), and collected in an autosampler vial.
Samples were injected on an UPLC system consisting of an Acquity H-Class Quaternary
Solvent Manager with temperature-controlled tray and column oven from Waters (Zellik, Belgium).
Chromatographic separation was achieved on an Acquity UPLC®HSS T3 column (100 mm× 2.1 mm I.D.,
particle size dp: 1.8 µm) in combination with an Acquity HSS T3 Vanguard pre-column (5 mm × 2.1 mm
I.D., dp: 1.8 µm) both from Waters. The UPLC system was coupled to a Xevo® TQ-S MS/MS system,
equipped with an ESI probe operating in both the positive and negative ionization mode (all from
Waters, Zellik, Belgium). Liquid chromatography and MS parameters were optimized as reported
in Debevere et al. [29]. The developed UPLC-MS/MS method was in-house validated by a set of
parameters that were in compliance with the recommendations set by the European Community [53]
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and with reference guidelines defined in other EU and FDA documents [54–56]. The method validation
and the acceptance criteria are reported in Debevere et al. [29].
MassLynx version 4.1 software was used for data processing (Copyright© 2012, Waters,
Zellik, Belgium).
4.6. Data Modeling and Statistical Analysis
The efficacy of the mycotoxin detoxifiers at low and/or normal pH was tested in triplicate and
all incubations were done in the same run. Statistical analyses were performed with RStudio version
1.2.5001 (Copyright© 2009–2018 R studio Inc., Boston, MA, USA) using R version 3.6.1. The mycotoxin
disappearance was assessed by a multilevel analysis using step forward model building including
random intercept of replicate, time and time2 as first level, pH, treatment, and their interaction as
second level, random slope of time and two-way interactions between time and second level effects.
All lower level interactions were included in the model if a higher-level interaction was significant.
Random factors, i.e., replicates and time, had no/limited effect on the model. All analyses were
performed using the lmer function in the lme4 package version 1.1–17 [57]. The model fit was evaluated
by the Akaike information criterion (AIC). For each model, R2m (marginal R2, variance explained
by fixed factors) was calculated using the MuMIn-package version 1.43.6 [58]. Model estimators are
represented with standard error (SE) in the tables. Values of p < 0.05 were considered statistically
significant. Graphs were constructed using ggplot2 package version 2.2.1 [59].
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